{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:31:32Z","timestamp":1786444292985,"version":"build-2736575974"},"reference-count":48,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15768","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:59:14Z","timestamp":1784264354000},"page":"1-12","source":"Crossref","is-referenced-by-count":0,"title":["A three\u2011gene signature correlated with MAPK\/ERK activation characterizes acquired resistance to EGFR\u2011tyrosine kinase inhibitors in non\u2011small cell lung cancer"],"prefix":"10.3892","volume":"32","author":[{"given":"Changtai","family":"Qin","sequence":"first","affiliation":[{"name":"School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghui","family":"Liang","sequence":"additional","affiliation":[{"name":"School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, University of California, San Diego, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology and Institute of Traditional Chinese Medicine in Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjie","family":"Ye","sequence":"additional","affiliation":[{"name":"School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"key20260811124543_b1-ol-32-3-15768","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20260811124543_b2-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"114900","DOI":"10.1016\/j.ejmech.2022.114900","article-title":"Recent advances of novel fourth generation EGFR inhibitors in overcoming C797S mutation of lung cancer therapy","volume":"245","author":"Xu","year":"2023","journal-title":"Eur J Med Chem"},{"key":"key20260811124543_b3-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"506","DOI":"10.21037\/tlcr.2020.03.40","article-title":"Epidemiology of stage III lung cancer: Frequency, diagnostic characteristics, and survival","volume":"10","author":"Casal-Mouri\u00f1o","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"key20260811124543_b4-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N Engl J Med"},{"key":"key20260811124543_b5-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"key20260811124543_b6-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-018-0793-1","article-title":"EGFR-TKIs resistance via EGFR-independent signaling pathways","volume":"17","author":"Liu","year":"2018","journal-title":"Mol Cancer"},{"key":"key20260811124543_b7-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal growth factor receptor mutations in lung cancer","volume":"7","author":"Sharma","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20260811124543_b8-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3892\/ijo.2021.5270","article-title":"Mechanisms and management of 3rd-generation EGFR-TKI resistance in advanced non-small cell lung cancer (review)","volume":"59","author":"He","year":"2021","journal-title":"Int J Oncol"},{"key":"key20260811124543_b9-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"eaan6566","DOI":"10.1126\/scitranslmed.aan6566","article-title":"A method of high-throughput functional evaluation of EGFR gene variants of unknown significance in cancer","volume":"9","author":"Kohsaka","year":"2017","journal-title":"Sci Transl Med"},{"key":"key20260811124543_b10-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.lungcan.2013.02.021","article-title":"Clinical perspective of afatinib in non-small cell lung cancer","volume":"81","author":"Chen","year":"2013","journal-title":"Lung Cancer"},{"key":"key20260811124543_b11-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.jtho.2017.08.025","article-title":"Acquired resistance to afatinib due to T790M-positive squamous progression in EGFR-mutant adenosquamous lung carcinoma","volume":"13","author":"Ricciuti","year":"2018","journal-title":"J Thorac Oncol"},{"key":"key20260811124543_b12-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1158\/1535-7163.MCT-18-0591","article-title":"KRAS and EGFR amplifications mediate resistance to rociletinib and osimertinib in acquired afatinib-resistant NSCLC harboring exon 19 deletion\/T790M in EGFR","volume":"18","author":"Nakatani","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"key20260811124543_b13-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/cas.13571","article-title":"Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations","volume":"109","author":"Torigoe","year":"2018","journal-title":"Cancer Sci"},{"key":"key20260811124543_b14-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1159\/000479147","article-title":"Adenocarcinoma of the lung acquiring resistance to afatinib by transformation to small cell carcinoma: A case report","volume":"10","author":"Nishimura","year":"2017","journal-title":"Case Rep Oncol"},{"key":"key20260811124543_b15-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"e0209384","DOI":"10.1371\/journal.pone.0209384","article-title":"Mechanisms of acquired resistance to afatinib clarified with liquid biopsy","volume":"13","author":"Nakamura","year":"2018","journal-title":"PLoS One"},{"key":"key20260811124543_b16-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"763035","DOI":"10.3389\/fonc.2021.763035","article-title":"Identification and validation of afatinib potential drug resistance gene BIRC5 in non-small cell lung cancer","volume":"11","author":"Zhu","year":"2021","journal-title":"Front Oncol"},{"key":"key20260811124543_b17-ol-32-3-15768","first-page":"1106","article-title":"Network rewiring, adaptive resistance and combating strategies in breast cancer","volume":"2","author":"Cremers","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"key20260811124543_b18-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"146930","DOI":"10.1016\/j.gene.2022.146930","article-title":"Adaptive resistance is not responsible for long-term drug resistance in a cellular model of triple negative breast cancer","volume":"850","author":"Kumar","year":"2023","journal-title":"Gene"},{"key":"key20260811124543_b19-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41540-025-00511-3","article-title":"Understanding therapeutic tolerance through a mathematical model of drug-induced resistance","volume":"11","author":"Gevertz","year":"2025","journal-title":"NPJ Syst Biol Appl"},{"key":"key20260811124543_b20-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.trecan.2019.02.003","article-title":"Polytherapy and targeted cancer drug resistance","volume":"5","author":"Chatterjee","year":"2019","journal-title":"Trends Cancer"},{"key":"key20260811124543_b21-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20260811124543_b22-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12935-024-03382-6","article-title":"DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-\u03b2\/Smad signaling pathway in lung adenocarcinoma","volume":"24","author":"Fan","year":"2024","journal-title":"Cancer Cell Int"},{"key":"key20260811124543_b23-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11095-022-03461-1","article-title":"TGF-\u03b2 signaling activation confers anlotinib resistance in gastric cancer","volume":"40","author":"Chen","year":"2023","journal-title":"Pharm Res"},{"key":"key20260811124543_b24-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2015.10.018","article-title":"TGF-\u03b21 induces erlotinib resistance in non-small cell lung cancer by down-regulating PTEN","volume":"77","author":"Shen","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"key20260811124543_b25-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1158\/1541-7786.MCR-16-0482","article-title":"Distinct afatinib resistance mechanisms identified in lung adenocarcinoma harboring an EGFR mutation","volume":"15","author":"Yamaoka","year":"2017","journal-title":"Mol Cancer Res"},{"key":"key20260811124543_b26-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"105","DOI":"10.20892\/j.issn.2095-3941.2020.0098","article-title":"Oncoprotein HBXIP promotes tumorigenesis through MAPK\/ERK pathway activation in non-small cell lung cancer","volume":"18","author":"Zhang","year":"2021","journal-title":"Cancer Biol Med"},{"key":"key20260811124543_b27-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"100240","DOI":"10.1016\/j.mcpro.2022.100240","article-title":"eEF2K activity determines synergy to cotreatment of cancer cells with PI3K and MEK inhibitors","volume":"21","author":"Hijazi","year":"2022","journal-title":"Mol Cell Proteomics"},{"key":"key20260811124543_b28-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.3390\/ijms23137353","article-title":"Immunomodulatory properties of PI3K\/AKT\/mTOR and MAPK\/MEK\/ERK inhibition augment response to immune checkpoint blockade in melanoma and triple-negative breast cancer","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20260811124543_b29-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"115518","DOI":"10.1016\/j.taap.2021.115518","article-title":"Polyphyllin I reverses the resistance of osimertinib in non-small cell lung cancer cell through regulation of PI3K\/Akt signaling","volume":"419","author":"Lai","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20260811124543_b30-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1158\/1535-7163.MCT-20-0909","article-title":"ASTX029, a novel dual-mechanism ERK inhibitor, modulates both the phosphorylation and catalytic activity of ERK","volume":"20","author":"Munck","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"key20260811124543_b31-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.3892\/etm.2017.4350","article-title":"Anticancer effects of \u03b2-elemene with hyperthermia in lung cancer cells","volume":"13","author":"Wu","year":"2017","journal-title":"Exp Ther Med"},{"key":"key20260811124543_b32-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13045-018-0651-z","article-title":"Mouse avatar models of esophageal squamous cell carcinoma proved the potential for EGFR-TKI afatinib and uncovered Src family kinases involved in acquired resistance","volume":"11","author":"Liu","year":"2018","journal-title":"J Hematol Oncol"},{"key":"key20260811124543_b33-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/cncr.32655","article-title":"ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib","volume":"126","author":"Li","year":"2020","journal-title":"Cancer"},{"key":"key20260811124543_b34-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s12033-024-01127-4","article-title":"DUSP1 promotes osimertinib drug-tolerant persistence by inhibiting MAPK\/ERK signaling in non-small cell lung cancer","volume":"67","author":"He","year":"2025","journal-title":"Mol Biotechnol"},{"key":"key20260811124543_b35-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1158\/0008-5472.CAN-16-2300","article-title":"SFK\/FAK signaling attenuates osimertinib efficacy in both drug-sensitive and drug-resistant models of EGFR-mutant lung cancer","volume":"77","author":"Ichihara","year":"2017","journal-title":"Cancer Res"},{"key":"key20260811124543_b36-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"113722","DOI":"10.1016\/j.yexcr.2023.113722","article-title":"The combination of osimertinib with Raf inhibitor overcomes osimertinib resistance induced by KRAS amplification in EGFR-mutated lung cancer cells","volume":"430","author":"Lee","year":"2023","journal-title":"Exp Cell Res"},{"key":"key20260811124543_b37-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10020-025-01086-9","article-title":"HSPA1A inhibits pyroptosis and neuroinflammation after spinal cord injury via DUSP1 inhibition of the MAPK signaling pathway","volume":"31","author":"He","year":"2025","journal-title":"Mol Med"},{"key":"key20260811124543_b38-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"114196","DOI":"10.1016\/j.jconrel.2025.114196","article-title":"Nanodrug-based therapeutic interventions for tumor-associated microbiota modulation","volume":"387","author":"Nie","year":"2025","journal-title":"J Control Release"},{"key":"key20260811124543_b39-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1158\/1078-0432.CCR-23-0645","article-title":"Tumor microenvironment modifications induced by afatinib in squamous cell carcinoma of the head and neck: A window-of-opportunity study (EORTC-90111-24111)","volume":"29","author":"Beyaert","year":"2023","journal-title":"Clin Cancer Res"},{"key":"key20260811124543_b40-ol-32-3-15768","first-page":"463","article-title":"Rethinking cancer","volume":"47","author":"Luo","year":"2025","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"key20260811124543_b41-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.7150\/thno.82690","article-title":"Nasopharyngeal carcinoma ecology theory: Cancer as multidimensional spatiotemporal \u2018unity of ecology and evolution\u2019 pathological ecosystem","volume":"13","author":"Luo","year":"2023","journal-title":"Theranostics"},{"key":"key20260811124543_b42-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12860-022-00448-z","article-title":"Ribosomal protein RPL5 regulates colon cancer cell proliferation and migration through MAPK\/ERK signaling pathway","volume":"23","author":"Zhang","year":"2022","journal-title":"BMC Mol Cell Biol"},{"key":"key20260811124543_b43-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.biopha.2018.04.136","article-title":"Anti-invasion and anti-metastasis effects of Valjatrate E via reduction of matrix metalloproteinases expression and suppression of MAPK\/ERK signaling pathway","volume":"104","author":"Sun","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"key20260811124543_b44-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41392-024-01875-4","article-title":"Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"key20260811124543_b45-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1038\/s41598-022-12995-8","article-title":"AXL\/CDCP1\/SRC axis confers acquired resistance to osimertinib in lung cancer","volume":"12","author":"Murakami","year":"2022","journal-title":"Sci Rep"},{"key":"key20260811124543_b46-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"1766192","DOI":"10.1080\/20013078.2020.1766192","article-title":"Monitoring HSP70 exosomes in cancer patients' follow up: A clinical prospective pilot study","volume":"9","author":"Chanteloup","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"key20260811124543_b47-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.3390\/cancers13153706","article-title":"Hsp70 in liquid biopsies-a tumor-specific biomarker for detection and response monitoring in cancer","volume":"13","author":"Werner","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20260811124543_b48-ol-32-3-15768","doi-asserted-by":"publisher","first-page":"101166","DOI":"10.1016\/j.xcrm.2023.101166","article-title":"Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinoma","volume":"4","author":"Qu","year":"2023","journal-title":"Cell Rep Med"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:45:47Z","timestamp":1786441547000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,17]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15768","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}